Ligand
Executive Summary
Signs $26 mil. agreement with Abbott to discover and develop drugs for anti-inflammatory indications. Under agreement announced July 7, Abbott will support up to $16 mil. in Ligand research and make a $10 mil. two-stage equity investment. Ligand will also receive milestone payments and royalties from products developed under the agreement